PHA Classroom

What treatments are prescribed to manage PH and connective tissue disease?

February 26, 2021

Stephen Mathai, M.D., M.H.S, discusses the importance of working with your health care team when treating pulmonary hypertension (PH) and connective tissue disease. Dr. Mathai gives an overview of considerations that should be evaluated when making treatment decisions for patients with connective tissue diseases and pulmonary hypertension. PHA thanks Janssen Pharmaceuticals, Inc. for its Diamond sponsorship of the PHA Connects fund, which sponsors patient education programming.